Gufic BioSciences Ltd. | Income Statement
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
1,206
1,490
2,010
2,482
3,010
Cost of Goods Sold (COGS) incl. D&A
896
1,152
1,537
1,831
2,064
Gross Income
311
338
472
651
945
SG&A Expense
216
220
306
415
606
Unusual Expense
-
-
-
-
16
Non Operating Income/Expense
6
3
3
6
29
Interest Expense
39
45
54
62
89
Pretax Income
63
65
112
180
295
Income Tax
20
24
39
66
135
Consolidated Net Income
43
42
73
114
160
Net Income
43
42
73
114
160
Net Income After Extraordinaries
43
42
73
114
160
Net Income Available to Common
43
42
73
114
160
EPS (Basic)
0.55
0.54
0.95
1.48
2.07
Basic Shares Outstanding
77
77
77
77
-
EPS (Diluted)
0.55
0.54
0.95
1.48
-
Diluted Shares Outstanding
77
77
77
77
-
EBITDA
119
144
204
271
382
Other Operating Expense
-
-
13
1
-
Non-Operating Interest Income
1
1
3
2
-
About Gufic BioSciences
View Profile
